Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson Disease Psychosis”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Testing effectiveness (Phase 2)WithdrawnNCT05344365
What this trial is testing

Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
Vanda Pharmaceuticals
Not applicableStudy completedNCT00360633
What this trial is testing

Psychiatric and Cognitive Manifestations of Parkinson's Disease

Who this might be right for
Parkinson's Disease
NYU Langone Health 36
Not applicableLooking for participantsNCT05635266
What this trial is testing

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Who this might be right for
Age-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more
Sanguine Biosciences 20,000
Large-scale testing (Phase 3)Study completedNCT01174004
What this trial is testing

The Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc. 199
Not applicableUnknownNCT04399096
What this trial is testing

Sound and Vision: A Collaboration Between Service-users, Artists and the Public to Explore the Lived Experience of Hallucinations

Who this might be right for
SchizophreniaParkinson DiseaseHallucinations
University of Cambridge 500
Post-approval studies (Phase 4)Looking for participantsNCT06634641
What this trial is testing

Clozapine-related Immunodeficiency in Parkinsons Disease

Who this might be right for
ClozapineParkinson's Disease (PD)Immunodeficiency+1 more
Centre Hospitalier Universitaire, Amiens 24
Early research (Phase 1)Not Yet RecruitingNCT06388551
What this trial is testing

A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017

Who this might be right for
Hallucinations and Delusions Associated With Alzheimer's Disease PsychosisHallucinations and Delusions Associated With Parkinson Disease PsychosisNegative Symptoms of Schizophrenia
Luye Pharma Group Ltd. 60
Post-approval studies (Phase 4)Looking for participantsNCT05357612
What this trial is testing

Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases

Who this might be right for
Neurodegenerative DiseasesParkinson DiseaseParkinson Disease Psychosis
Vanderbilt University Medical Center 75
Testing effectiveness (Phase 2)Study completedNCT02818777
What this trial is testing

Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University of Colorado, Denver 13
Early research (Phase 1)Not Yet RecruitingNCT06980207
What this trial is testing

A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017

Who this might be right for
Hallucinations and Delusions Associated With Alzheimer's Disease PsychosisHallucinations and Delusions Associated With Parkinson Disease PsychosisNegative Symptoms of Schizophrenia
Luye Pharma Group Ltd. 40
Very early researchWithdrawnNCT05796167
What this trial is testing

Pimavanserin for Sleep in Parkinson Disease

Who this might be right for
Parkinson Disease
State University of New York - Downstate Medical Center
Testing effectiveness (Phase 2)Study completedNCT03582137
What this trial is testing

Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease

Who this might be right for
Parkinson Disease
University of Colorado, Denver 74
Not applicableStudy completedNCT02409823
What this trial is testing

Clinical Registry of Patients Under Treatment With Atypical Antipsychotics

Who this might be right for
SchizophreniaMajor Depressive DisorderBipolar Depressive Disorder+1 more
Pontifical Catholic University of Argentina 665
Early research (Phase 1)Study completedNCT06450184
What this trial is testing

Bioequivalence Study of Pimavanserin 34 mg Capsule

Who this might be right for
Parkinson Disease Psychosis
Humanis Saglık Anonim Sirketi 32
Large-scale testing (Phase 3)Study completedNCT03325556
What this trial is testing

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

Who this might be right for
Dementia-related Psychosis
ACADIA Pharmaceuticals Inc. 392
Large-scale testing (Phase 3)Looking for participantsNCT06068465
What this trial is testing

The Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
Tasly Pharmaceutical Group Co., Ltd 248
Testing effectiveness (Phase 2)Study completedNCT02969369
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 39
Large-scale testing (Phase 3)Study completedNCT00550238
What this trial is testing

The Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc. 459
Not applicableApproved For MarketingNCT02762591
What this trial is testing

Expanded Access of Pimavanserin for Patients With PD Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc.
Post-approval studies (Phase 4)Looking for participantsNCT04373317
What this trial is testing

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Who this might be right for
Parkinson's Disease Psychosis
VA Office of Research and Development 358
Load More Results